Bellevue Group »

Akero Therapeutics shares owned by Bellevue Group

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.3M 25k 50.58
2023-06-30 $1.3M 27k 46.69
2023-03-31 $999k 26k 38.26
2022-12-31 $2.3M 43k 54.80
2022-09-30 $1.4M 42k 34.06